Sercan Güvenışık

Recent publications · Crossref

5 total works indexed

1. Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study

   · 2019 · cited 2,827x

2. Temporal Fusion Transformers for interpretable multi-horizon time series forecasting

   · 2021 · cited 2,225x

3. TabNet: Attentive Interpretable Tabular Learning

   · 2021 · cited 1,277x

4. Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

   · 2017 · cited 503x

5. Rule-Based Control of Battery Energy Storage for Dispatching Intermittent Renewable Sources

   · 2010 · cited 478x

via Crossref · CC0